Enzyvant Therapeutics, Inc. develops biopharmaceutical products. It focuses on developing transformative therapies for rare diseases with high unmet needs. The company is headquartered in Cambridge, MA.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

SyStemix develops cellular and cell-based gene therapies for cancer, AIDS, and genetic diseases based on the use of isolated, expanded, and gene-modified hematopoietic stem cells. The company is based in Palo Alto, California. SyStemix, Inc. was acquired by Novartis AG. In February 1997, SyStemix completed a merger with Novartis Biotech Holding Corp., an indirect wholly owned subsidiary of Novartis, Inc. Novartis shuttered Systemix in 2000.

Norwood Immunology Pty Ltd. develops and commercializes immunology-related technologies for medical technology. The company was founded in December 2000 and is headquartered in Melbourne, Australia.

Enzyvant Therapeutics GmbH, a subsidiary of Sumitomo Chemical Co., Ltd., is a company headquartered in Basel, Switzerland, that operates as a biotechnology company which focuses on developing treatments for rare diseases. William T. Symonds is the current CEO, occupying that position since 2022.

Wuhan Hualong Biopharmaceutical Co., Ltd., established on 2000-10-10, Business scope includes production and sales of freeze-dried powder injections,large volume injection(glass infusion bottle,Polypropylene infusion bottle1Line),small volume injection,API(Ganciclovir);And the import and export trade of the above commodities(Excluding distribution business of imported goods).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Taichuang Biotechnology Co., Ltd., established on 2012-07-09, Business scope includes animals,Research and development of plant biochemical substance extraction technology,consult,Serve;animal,Extraction and processing of plant biochemical substances,Sales;Purchase of livestock products,Sales(Except for national key protected wild animals or their products);Chemical Products(non-flammable,Explosive,Precursor Hazardous Chemicals)Wholesale and retail;agricultural products(Does not contain grain)buy,Wholesale and retail;Conference Services;Undertake exhibition display service;Building intelligent integration engineering construction;drinks,food,Health food manufacturing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Qingdao Runda Biotechnology Co., Ltd., established on 2006-06-28, Business scope includes production,sales of veterinary drugs,Feed additives(Carry out business activities in accordance with the relevant licenses issued by the competent authority);Phage technology research and development,Production,Sales;Biotechnology new drug research and development;Import and export of goods and technology.(law,Except for items prohibited by administrative regulations,law,Projects restricted by administrative regulations can only be operated after obtaining a license;Projects that require approval according to law can only be operated after being approved by relevant departments).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)